EGFR and cancer: Moreover, TMEM43 was identified to activate the nuclear factor kappa B (NF-kB) pathway through epidermal growth factor receptor (EGFR) signaling or stabilize pre-MRNA processing factor 3 (PRPF3), thus promoting cancer cell proliferation, survival, and migration [12,14].